Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.
Saved in:
| Title: | Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. |
|---|---|
| Authors: | Price MJ (AUTHOR), Berger PB (AUTHOR), Teirstein PS (AUTHOR), Tanguay JF (AUTHOR), Angiolillo DJ (AUTHOR), Spriggs D (AUTHOR), Puri S (AUTHOR), Robbins M (AUTHOR), Garratt KN (AUTHOR), Bertrand OF (AUTHOR), Stillablower ME (AUTHOR), Aragon JR (AUTHOR), Kandzari DE (AUTHOR), Stinis CT (AUTHOR), Lee MS (AUTHOR), Manoukian SV (AUTHOR), Cannon CP (AUTHOR), Schork NJ (AUTHOR), Topol EJ (AUTHOR), GRAVITAS Investigators (CORPORATE AUTHOR) |
| Source: | JAMA: Journal of the American Medical Association. 3/16/2011, Vol. 305 Issue 11, p1097-1105. 9p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00987484 |
|---|---|
| DOI: | 10.1001/jama.2011.290 |
